Hospital in Clark Freeport opens TB center | Inquirer News

Hospital in Clark Freeport opens TB center

/ 06:38 PM October 13, 2021

Hospital in Clark Freeport opens TB center

The Medical City in Clark Freeport established a center that finds and treats tuberculosis patients, including children. (Contributed photo)

CLARK FREEPORT—The Medical City (TMC) Clark has opened a Tuberculosis Directly Observed Treatment Short-course (TB DOTS) Center here to help the Department of Health reduce the currently documented 66,000 TB cases in the Central Luzon region.

Inaugurated last Oct. 6, the TB DOTS Center’s goal is to “find and treat as many TB patients as possible.” Bacteria cause the disease.

Article continues after this advertisement

“The center is our way of opening our doors to the community as part of our nation-building,” Dr. Jacqueline Angeles, TMC Clark Medical Director, said in a statement on Wednesday.

FEATURED STORIES

The TB medicines would be provided by DOH, TMC marketing and sales chief Evelyn Yumul told the Inquirer.

Based on community surveillance, the DOH regional office reckoned there could be more TB patients who do not seek medical help.

Article continues after this advertisement

The United States Agency International Development has been providing GeneXpert technology to DOH, enabling the agency to detect TB, including the drug-resistant one in just hours instead of weeks.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: Clark

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.